Last Updated: August 3, 2026

Litigation Details for Pfizer Inc. v. Apotex Inc. (D. Del. 2018)


✉ Email this page to a colleague

« Back to Dashboard


Pfizer Inc. v. Apotex Inc. (D. Del. 2018)

Docket 1:18-cv-00795-RGA Date Filed 2018-05-25
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Richard Gibson Andrews
Jury Demand None Referred To
Patents 8,791,140
Link to Docket External link to docket
Small Molecule Drugs cited in Pfizer Inc. v. Apotex Inc.
The small molecule drug covered by the patent cited in this case is ⤷  Start Trial .

Details for Pfizer Inc. v. Apotex Inc. (D. Del. 2018)

Date Filed Document No. Description Snippet Link To Document
2018-05-25 1 Complaint prior to the expiration of U.S. Patent No. 8,791,140 (“the ’140 patent”). … CLAIM FOR RELIEF – INFRINGEMENT OF U.S. PATENT NO. 8,791,140 38. Pfizer incorporates each… 1. This is an action for patent infringement under the patent laws of the United States, Title… No. 211650, Defendants would infringe a patent or patents owned by Pfizer, a Delaware corporation, and…the United States Patent and Trademark Office (“PTO”) on July 29, 2014. The ’140 patent is listed in the External link to document
2018-05-25 130 Stipulation of Dismissal STIPULATION of Dismissal of Claims 5 and 6 of U.S. Patent No. 8,791,140, by Apotex Corp., Apotex, Inc.. (Phillips… 25 May 2018 1:18-cv-00795-RGA 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2018-05-25 131 Order Stipulation of Dismissal of Claims 5 and 6 of U.S. Patent No. 8,791,140. Signed by Judge Richard G. Andrews on 12… 25 May 2018 1:18-cv-00795-RGA 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2018-05-25 20 SERVICE of Infringement Contentions for U.S. Patent No. 8,791,140 filed by PF Prism C.V., Pfizer Inc., Pfizer… 25 May 2018 1:18-cv-00795-RGA 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.